This webinar presents the patient perspective, electrophysiological research, and technologies used as we work towards a potential treatment for KCNC1-related disorders.
Access to high quality compound libraries enables greater flexibility and increases diversity and enables us to maximise customer R&D budgets even more effectively.
The combination of our specialist ion channel expertise with substantial high-throughput screening (HTS) and hit-finding experience gives customers access to a dedicated team of drug discovery scientists, ensuring the correct strategic choices are made in compounds selected for screening. We also provide a Structured Data File (SDF) of all libraries to compare against existing libraries, further increasing efficiency.
Enamine have the world’s largest compound collection, including CNS and ion channel focused target libraries. Specifically, the Hit Locator Library (HLL) contains 460,000 compounds which we can split into screening sets, giving customers the benefit of cost efficiencies in the number of compounds screened. In addition, analog-by-catalog from Enamine in-stock and make-on-demand REAL libraries presents a fast and efficient way for hit expansion and SAR studies. Read the press release.
Assay.Works combine non-redundant small molecule sets as modular high-throughput screening decks. Access to 150,000 small molecule compounds optimized for lead-likeness and diversity, free of undesirable chemotypes, verified by LC/UV/MS.
Our specialist ion channel screening scientists have extensive experience in providing high quality biology services for ion channel targets. We work flexibly to suit the needs of your project and budget.
This webinar presents the patient perspective, electrophysiological research, and technologies used as we work towards a potential treatment for KCNC1-related disorders.
We developed a high-throughput, electrophysiological assay of TREK-1 function to identify novel modulators. The assay was optimized to identify both activators and inhibitors, providing comprehensive mechanistic data for high value, limited supply screening libraries, such as the venom fraction library used in this study (Targeted Venom Discovery Array, T-VDA, Venomtech, UK).